These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 25423883)

  • 1. Enhancement of in vitro activity of tuberculosis drugs by addition of thioridazine is not reflected by improved in vivo therapeutic efficacy.
    de Knegt GJ; Ten Kate MT; van Soolingen D; Aarnoutse R; Boeree MJ; Bakker-Woudenberg IA; de Steenwinkel JE
    Tuberculosis (Edinb); 2014 Oct; ():. PubMed ID: 25423883
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhancement of in vitro activity of tuberculosis drugs by addition of thioridazine is not reflected by improved in vivo therapeutic efficacy.
    de Knegt GJ; ten Kate MT; van Soolingen D; Aarnoutse R; Boeree MJ; Bakker-Woudenberg IA; de Steenwinkel JE
    Tuberculosis (Edinb); 2014 Dec; 94(6):701-7. PubMed ID: 25621361
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SILA-421 activity in vitro against rifampicin-susceptible and rifampicin-resistant Mycobacterium tuberculosis, and in vivo in a murine tuberculosis model.
    de Knegt GJ; Bakker-Woudenberg IA; van Soolingen D; Aarnoutse R; Boeree MJ; de Steenwinkel JE
    Int J Antimicrob Agents; 2015 Jul; 46(1):66-72. PubMed ID: 25951996
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduced emergence of isoniazid resistance with concurrent use of thioridazine against acute murine tuberculosis.
    Dutta NK; Pinn ML; Karakousis PC
    Antimicrob Agents Chemother; 2014 Jul; 58(7):4048-53. PubMed ID: 24798290
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tedizolid, Faropenem, and Moxifloxacin Combination With Potential Activity Against Nonreplicating
    Srivastava S; Cirrincione KN; Deshpande D; Gumbo T
    Front Pharmacol; 2020; 11():616294. PubMed ID: 33542690
    [No Abstract]   [Full Text] [Related]  

  • 6. Chemotherapeutic efficacy of thioridazine as an adjunct drug in a murine model of latent tuberculosis.
    Singh A; Sharma S
    Tuberculosis (Edinb); 2014 Dec; 94(6):695-700. PubMed ID: 25305001
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Xpert MTB/XDR for detection of pulmonary tuberculosis and resistance to isoniazid, fluoroquinolones, ethionamide, and amikacin.
    Pillay S; Steingart KR; Davies GR; Chaplin M; De Vos M; Schumacher SG; Warren R; Theron G
    Cochrane Database Syst Rev; 2022 May; 5(5):CD014841. PubMed ID: 35583175
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sterilizing activity of thioridazine in combination with the first-line regimen against acute murine tuberculosis.
    Dutta NK; Pinn ML; Karakousis PC
    Antimicrob Agents Chemother; 2014 Sep; 58(9):5567-9. PubMed ID: 24936590
    [TBL] [Abstract][Full Text] [Related]  

  • 9. API TB Consensus Guidelines 2006: Management of pulmonary tuberculosis, extra-pulmonary tuberculosis and tuberculosis in special situations.
    API Consensus Expert Committee
    J Assoc Physicians India; 2006 Mar; 54():219-34. PubMed ID: 16800350
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficiency and safety of the combination of moxifloxacin, pretomanid (PA-824), and pyrazinamide during the first 8 weeks of antituberculosis treatment: a phase 2b, open-label, partly randomised trial in patients with drug-susceptible or drug-resistant pulmonary tuberculosis.
    Dawson R; Diacon AH; Everitt D; van Niekerk C; Donald PR; Burger DA; Schall R; Spigelman M; Conradie A; Eisenach K; Venter A; Ive P; Page-Shipp L; Variava E; Reither K; Ntinginya NE; Pym A; von Groote-Bidlingmaier F; Mendel CM
    Lancet; 2015 May; 385(9979):1738-1747. PubMed ID: 25795076
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapy Of XDR TB with thioridazine a drug beyond patent protection but eligible for patent "as new use".
    Amaral L; Molnar J
    Recent Pat Antiinfect Drug Discov; 2010 Jun; 5(2):109-14. PubMed ID: 20156179
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The use of Mycobacterium tuberculosis H37Ra-infected immunocompetent mice as an in vivo model of persisters.
    Kumari N; Sharma R; Ali J; Chandra G; Singh S; Krishnan MY
    Tuberculosis (Edinb); 2024 Mar; 145():102479. PubMed ID: 38262199
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of the efficacy of clofazimine alone and in combination with primary agents against Mycobacterium tuberculosis in vitro.
    Mashele SA; Steel HC; Matjokotja MT; Rasehlo SSM; Anderson R; Cholo MC
    J Glob Antimicrob Resist; 2022 Jun; 29():343-352. PubMed ID: 35339735
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genotypic and phenotypic comparison of drug resistance profiles of clinical multidrug-resistant Mycobacterium tuberculosis isolates using whole genome sequencing in Latvia.
    Vīksna A; Sadovska D; Berge I; Bogdanova I; Vaivode A; Freimane L; Norvaiša I; Ozere I; Ranka R
    BMC Infect Dis; 2023 Sep; 23(1):638. PubMed ID: 37770850
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Colistin as a potentiator of anti-TB drug activity against Mycobacterium tuberculosis.
    Bax HI; de Steenwinkel JE; Ten Kate MT; van der Meijden A; Verbon A; Bakker-Woudenberg IA
    J Antimicrob Chemother; 2015 Oct; 70(10):2828-37. PubMed ID: 26183185
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment outcomes for isoniazid-monoresistant tuberculosis in Peru, 2012-2014.
    Cornejo Garcia JG; Alarcón Guizado VA; Mendoza Ticona A; Alarcon E; Heldal E; Moore DAJ
    PLoS One; 2018; 13(12):e0206658. PubMed ID: 30513085
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mycobacterial Protein Tyrosine Phosphatases A and B Inhibitors Augment the Bactericidal Activity of the Standard Anti-tuberculosis Regimen.
    Dutta NK; He R; Pinn ML; He Y; Burrows F; Zhang ZY; Karakousis PC
    ACS Infect Dis; 2016 Mar; 2(3):231-239. PubMed ID: 27478867
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Delamanid Kills Dormant Mycobacteria
    Chen X; Hashizume H; Tomishige T; Nakamura I; Matsuba M; Fujiwara M; Kitamoto R; Hanaki E; Ohba Y; Matsumoto M
    Antimicrob Agents Chemother; 2017 Jun; 61(6):. PubMed ID: 28373190
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The antipsychotic thioridazine shows promising therapeutic activity in a mouse model of multidrug-resistant tuberculosis.
    van Soolingen D; Hernandez-Pando R; Orozco H; Aguilar D; Magis-Escurra C; Amaral L; van Ingen J; Boeree MJ
    PLoS One; 2010 Sep; 5(9):. PubMed ID: 20844587
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.